Docetaxel Induced Durable Response in Advanced Extramammary Paget's Disease: A Case Report
- 1 January 2002
- journal article
- case report
- Published by Wiley in The Journal of Dermatology
- Vol. 29 (1), 33-37
- https://doi.org/10.1111/j.1346-8138.2002.tb00162.x
Abstract
The patient was a 54‐year‐old Japanese man with a seven‐month history of an eroded lesion on the scrotum. Skin biopsy confirmed the diagnosis of extramammary Paget's disease, and a CT scan revealed multiple metastases to the lymph nodes along the iliac artery and aorta. The patient underwent combination chemotherapy with mitomycin C, epirubicin, vincristine, cisplatin, and 5‐fluorouracil. After two courses of the regimen, the primary lesions on the scrotum regressed, however, the lymph node metastases did not respond. A regimen of continuous administration of low‐dose cisplatin and 5‐fluorouracil was not effective for the metastases either. Hence, administration of docetaxel at a dose of 60 mg/m2/every four weeks was started. After two courses, the lymph node metastases decreased by 75% compared to the pre‐treatment size, and the effect was judged a partial response. The major toxicities were neutropenia, alopecia, pitting edema, and facial erythema, but these were tolerable. Five courses of this regimen were followed by four courses of weekly administration of 25 mg/m2 docetaxel. The partial response persisted for more than 12 months and the patient was able to enjoy daily life. Docetaxel may be an effective drug for patients with advanced extramammary Paget's disease.Keywords
This publication has 9 references indexed in Scilit:
- Metastatic eccrine porocarcinoma: Response to docetaxel (Taxotere) chemotherapyAnnals of Oncology, 2001
- Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinomaCancer, 2000
- Paclitaxel in the treatment of patients with angiosarcoma of the scalp or faceCancer, 1999
- Phase II Trial of Docetaxel, Cisplatin, Fluorouracil, and Leucovorin as Induction for Squamous Cell Carcinoma of the Head and NeckJournal of Clinical Oncology, 1999
- Recent Advances in the Medicinal Chemistry of Taxoids with Novel P-Amino Acid Side ChainsCurrent Medicinal Chemistry, 1999
- A Case of Metastatic Extramammary Paget's Disease That Responded to Combination ChemotherapyThe Journal of Dermatology, 1999
- Phase II Trial of Paclitaxel in Patients with Soft-Tissue SarcomaCancer Investigation, 1998
- A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancerBritish Journal of Cancer, 1996
- Metastatic extramammary Paget's disease: Dramatic response to combined modality treatmentJournal of Surgical Oncology, 1988